Todd Garland Joins Cytek Biosciences As Chief Commercial Officer
pharmatechoutlook

Pharma Tech Outlook: Pharma Tech Magazine

Todd Garland Joins Cytek Biosciences As Chief Commercial Officer

Pharma Tech Outlook | Tuesday, May 03, 2022

Cytek Biosciences, Inc. is a major cell analysis solutions company that delivers high-resolution, high-content, and high-sensitivity cell analysis through its patented Full Spectrum Profiling (FSP) technology, advancing the next generation of cell analysis tools.

FREMONT, CA: “I have long admired Cytek’s advanced technology and products, and I am particularly pleased to join the company because I believe Cytek has a real opportunity to become the premier company in the cell analysis industry,” commented Garland.

Cytek Biosciences, a leading provider of cell analysis solutions, declared the appointment of Todd Garland as Chief Commercial Officer. Garlands' appointment takes effect immediately, and he will report directly to Dr. Wenbin Jiang, Chairman, and CEO of Cytek Biosciences.

Garlands' previous professional experience includes stints at BD Biosciences, CareFusion, and Cardinal Health, where he held various executive leadership roles in commercial and marketing.

Todd’s extensive management experience in the life science industry will be integral to growing and strengthening Cytek’s commitment to serving customers using our Full Spectrum Profiling technology, while augmenting our worldwide sales and customer support capabilities” said Dr. Jiang. I’m also pleased to have Todd join Cytek’s executive team to support the continued expansion of our business and help us execute on our growth opportunities.”

Garland holds a Master of Business Administration in Finance and Marketing from the University of Michigan's Stephen M. Ross School of Business and a Bachelor of Science in Accounting from California Polytechnic State University. In the state of California, he is a Certified Public Accountant.

Weekly Brief

Read Also